Results
Sudarshan Pharma Q2 Net Profit Rises 77% YoY
• Board approved Q2 FY27 standalone net profit of ₹7.80 crore, up 77% year-on-year from ₹4.40 crore.
• Company raised funds via FCCB issuance of $10 million and completed warrant conversion, increasin
